Articles by tag: fda-breakthrough

Motif Neurotech implant for depression: breakthrough FDA status 2026

Implantable vagus nerve stimulator Motif DOT reduces MADRS by 65% in 8 weeks. Learn how bioelectronics is changing the treatment of resistant depression. Read details.

AI diagnosis of bladder cancer: 99% accuracy and Vesta breakthrough

AI increases accuracy of bladder cancer diagnosis to 99%. Analysis of the VisioCyt vs Vesta battle: who received FDA breakthrough status and why it changes urology. Read.